LGC

Teddington, United Kingdom Founded: 1842 • Age: 184 yrs Acquired By Astorg Partners
Molecular biology reagents and services are supplied to biotech industries.

About LGC

LGC is a Healthcare company based in Teddington (United Kingdom) founded in 1842, and was acquired by Astorg Partners in November 2019. Molecular biology reagents and services are supplied to biotech industries. The company has 901 employees. LGC has completed 14 acquisitions, including BRCGS, BioAutomation and Douglas Scientific. Its website lgcgroup.com draws about 28 thousand monthly visits. LGC offers products and services including KASP Technology, AccuPlex Monkeypox Reference Material Kit, and Reference Materials for PFAS. Its focus areas include Life Sciences, Genomics, Diversified and Life Sciences Platforms and Tools. Its legal entity is LGC LIMITED. Its competitors include Horizon Discovery and Source BioScience; 1 of its 2 listed competitors has raised funding.

Company details

LGC was founded in 1842 and is based in Teddington, United Kingdom, where biological testing and research services are provided to biotechnology and pharmaceutical sectors. Operations include DNARNA extraction, genotyping, DNA sequencing, drugs and alcohol testing, forensic analysis, and food and agricultural product evaluation. Reference materials, proficiency testing, genomic products, and lab management solutions are also offered alongside analytical instruments.

  • Headquarters Teddington, United Kingdom
  • Employees 901
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website lgcgroup.com
  • Social LinkedIn X Facebook
  • Acquired by Astorg Partners (Nov 2019)
  • Legal Name Lgc Limited
  • Date of Incorporation 18 Nov, 1994
  • Jurisdiction MIDDLESEX
Key Metrics
  • Annual Revenue
    $191.02 M (USD)
    7
    as on Mar 31, 2024
  • Net Profit
    $9.94 M (USD)
    -63
    as on Mar 31, 2024
  • EBITDA
    $9.01 M (USD)
    -69
    as on Mar 31, 2024
  • Latest Funding Round
    $67.55K (USD), Grant

    Dec 2021

  • Investors
    KKR

    & 6 more

  • Employee Count
    901
  • Investments & Acquisitions
    BRCGS

    & 13 more

  • Acquired by
    Astorg Partners

    & 2 more

    (Nov 2019)

Products & Services of LGC

LGC offers a comprehensive portfolio of products and services, including KASP Technology, AccuPlex Monkeypox Reference Material Kit, and Reference Materials for PFAS.

KASP Technology
Genotyping Tool

Enables precise DNA analysis for conservation and agriculture research.

AccuPlex Monkeypox Reference Material Kit
Diagnostic Kit

Supports assay development for disease detection and quality control.

Reference Materials for PFAS
Testing Standards

Facilitates accurate chemical analysis in environmental and food safety.

Funding Insights of LGC

  • Total Rounds 16
  • Last Round Grant β€” $67,547
  • First Round $750,000

    (Jun 2009)

  • Investors Count 2

Latest 10 of 16 funding rounds of LGC with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2021$67,547Grant––
Sep 2021$60,650Grant––
Nov 2019$365,146Grant––
Apr 2019$24,808Grant––
Feb 2019$293,401Grant––
Jan 2019$365,146Grant––
Jan 2019$293,401Grant––
Sep 2018Grant––
May 2018$81,641Grant––
Jun 2017Grant––
Valuation history

7 investors in total: 7 institutional.

Investors in LGC

LGC has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include KKR, HHS and Bridgepoint Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity investments and portfolio management services are provided by Cinven across various sectors.
cinven.com
Multiple sectors are invested in by this private equity firm.
1976kkr.comNew York, United States
Astorg is engaged in private equity investment management.
astorg.comParis, France
Middle-market businesses up to €1 billion are acquired pan-Europe.
1984bridgepoint.euFrankfurt, Germany
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Public health and human services are overseen by HHS.
1953hhs.gov
Long-term value is created through diversified sovereign wealth investments.
adia.aeAbu Dhabi, United Arab Emirates
Premium access

Investor details for LGC

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of LGC

19 people are tracked at LGC (7 in leadership, 8 in board & advisors, 4 in team); the tracked headcount is 901.

NameRoleGroup
Joydeep Goswami
President & CEOLeadership
Julie Cormack
Chief People OfficerLeadership
Lee Maw
Chief Digital & Information OfficerLeadership
Marcus Kaeller
CFOLeadership
Manjeet Aujla
Chief Transformation OfficerLeadership
Alexander Zahiri
EVP & General Manager, AxolabsLeadership
Ken Yoon
EVP & General Manager, Diagnostics & GenomicsLeadership
James Davis
Non Executive DirectorBoard & advisors
Matthew Norton
Non Executive DirectorBoard & advisors
Supraj Rajagopalan
Non Executive DirectorBoard & advisors
Tish S Creasey
Non Executive DirectorBoard & advisors
Nicolas Roelofs
Non Executive DirectorBoard & advisors
François De Mitry
Non Executive DirectorBoard & advisors
David P. King
Non-Executive Director & ChairmanBoard & advisors
James Halliday
Non-Executive DirectorBoard & advisors
Bharathi Anekella
EVP, Diagnostics & Genomics Innovation HubTeam
Sanjeev Rana
SVP, Corporate Strategy, Development & CommunicationsTeam
Helen Watson
General Counsel & Company SecretaryTeam
Bruno Rossi
EVP & GM, LGC StandardsTeam
Premium access

Complete people profiles for LGC

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by LGC

LGC has strategically engaged in corporate development activities, having acquired 14 companies. Notable acquisitions include BRCGS, BioAutomation and Douglas Scientific.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Standards and controls for urinalysis testing are developed and manufactured.
kovaintl.comGarden Grove, United States2012Jul 2023β€’β€’β€’β€’
DNA sequencing services are provided for crop and livestock improvement.
rapid-genomics.comGainesville, United States2011Apr 2022β€’β€’β€’β€’
Laboratory reagents, calibration standards, testing equipment, and instruments are manufactured.
paragon-sci.comBirkenhead, United Kingdom1994Mar 2021β€’β€’β€’β€’
Quality control materials and informatics solutions for clinical diagnostics.
technopathclinicaldiagnostics.com0Feb 2021β€’β€’β€’β€’
Development and manufacture of native and recombinant viral and bacterial antigens
thenativeantigencompany.comUpper Heyford, United Kingdom2010Jul 2020β€’β€’β€’β€’
Certified reference materials are supplied for spectroscopic and spectrochemical analysis.
mbh.co.ukBarnet, United Kingdom1973Dec 2018β€’β€’β€’β€’
Provider of biological materials/products that help optimize diagnostic performance, reliability and repeatability
seracare.comMilford, United States1984Nov 2018β€’β€’β€’β€’
Developer of oligonucleotide synthesizer and synthesis reagents
bioautomation.comIrving, United States1999May 2018β€’β€’β€’β€’
Lucigen is engaged in developing molecular biology enzymes and reagents.
lucigen.comMiddleton, United States1998Feb 2018β€’β€’β€’β€’
Global supply chain assurance is provided through trusted certification programs.
brcgs.comGuildford, United Kingdom0Nov 2016β€’β€’β€’β€’
Premium access

Complete acquisition details for LGC

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of LGC

16 dated milestones of LGC across 181 years, from founding to its latest funding, stage changes and deals.

  1. Founded LGC is founded.
  2. Funding First funding round of $750K.
  3. Exit Acquired by Bridgepoint Capital.
  4. Exit Acquired by KKR.
  5. Acquisition Acquires BRCGS.
  6. Acquisition Acquires Lucigen.
  7. Acquisition Acquires BioAutomation.
  8. Acquisition Acquires SeraCare.
  9. Acquisition Acquires MBH Analytical.
  10. Exit Acquired by Astorg Partners.
  11. Acquisition Acquires Native Antigen.
  12. Acquisition Acquires Technopath Clinical Diagnostics.
  13. Acquisition Acquires Paragon Scientific.
  14. Funding Latest funding round, Grant, of $68K.
  15. Acquisition Acquires Rapid Genomics.
  16. Acquisition Acquires KOVA International.

Competitors of LGC

LGC has 2 listed competitors in our database, 1 of them funded. They include Horizon Discovery and Source BioScience.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
horizondiscovery.com2007Cambridge, United Kingdom$46.29M432
Genetically modified cell lines are developed using AAV gene-editing platform.
sourcebioscience.com1903Nottingham, United Kingdom273
Multiple genomic services are provided for analysis and diagnostics.
Premium access

Detailed competitors of LGC

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of LGC

The website of LGC (lgcgroup.com) receives about 27.8K visits a month.

  • Monthly visits
    27.8K

    ▲ 50.9% vs previous month

Similar websites

Websites whose visitors overlap most with LGC. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
lgcgenomics.com
100%
View details
biosearchtech.com
91%
52K#598,672View details
all-about-forensic-science.com
all-about-forensic-science.com
86%
#3,646,264–
lgcstandards.com
74%
228.5K#179,043View details
npl.co.uk
59%
225.6K#212,616View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 11 similar websites and full traffic analytics for LGC

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 11 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

2 companies that operate in the same segment as LGC (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lgc

Premium access

Complete news archive for LGC

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about LGC

LGC was founded in 1842 and raised its 1st funding round 167 years after it was founded.

LGC is headquartered in Teddington, United Kingdom. It is registered at Teddington, Greater London, United Kingdom.

LGC has 901 employees.

Annual revenue of LGC is $191.02M as on Mar 31, 2024.

LGC was founded in 1842 and is based in Teddington, United Kingdom, where biological testing and research services are provided to biotechnology and pharmaceutical sectors. Operations include DNARNA extraction, genotyping, DNA sequencing, drugs and alcohol testing, forensic analysis, and food and agricultural product evaluation. Reference materials, proficiency testing, genomic products, and lab management solutions are also offered alongside analytical instruments.

LGC's top competitors include Horizon Discovery and Source BioScience.

LGC offers KASP Technology, AccuPlex Monkeypox Reference Material Kit, and Reference Materials for PFAS.

LGC has made 14 acquisitions, including BRCGS, BioAutomation, and Douglas Scientific.

LGC has 7 investors. Key investors include KKR, HHS, Bridgepoint Capital, European Union, and Abu Dhabi Investment Authority.

LGC operates through Lgc Limited.

Yes. LGC was acquired by Astorg Partners in November 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available